FTC Loses Reconsideration Bid In AbbVie Pay-For-Delay Suit
A Pennsylvania federal judge refused Tuesday to revive the Federal Trade Commission's pay-for-delay antitrust claims against AbbVie Inc. and Teva Pharmaceuticals USA Inc. over Androgel, saying the Third Circuit's recent ruling...To view the full article, register now.
Already a subscriber? Click here to view full article